Findings show new therapy has potential to help the brain as it reacts to stroke’s harmful effects. Researchers at the...
An experimental drug that reduces brain damage and improves motor skills among stroke-afflicted rodents when given with federally approved clot-busting therapy has been created.
An experimental drug appears to reduce brain damage, improve motor skills and eliminate hemorrhaging in older stroke afflicted rodents.
Using optogenetics to stimulate mice brains five days after a stroke helped improve motor control and brain chemistry, researchers report.
A new study reports an anti-epilepsy drug could reduce the debilitating impact of strokes.
Tissue plasminogen activators (tPA), FDA approved drugs used to treat stroke and heart attack patients, may help COVID-19 patients in danger of respiratory failure. If successful, the drug may help treat severe respiratory symptoms when ventilators are not available.
A new clinical trial is being established to see if anti-clotting drugs, commonly used for heart attack and stroke patients, can help treat COVID-19 patients who develop ARDS. If successful, the tPA drugs could help alleviate the expected ventilator shortage problem we are likely to experience soon.
An aerosolized version of tissue plasminogen activator (tPA), a clot-busing drug commonly used for the treatment of stroke patients, could target blood clots that form as a result of severe coronavirus infection.
Direct carotid puncture is a safe and effective alternative to thrombectomy for stroke patients.
